Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine

Biological Psychiatry
Donald C GoffPerry F Renshaw

Abstract

Recent evidence suggests that effects upon glutamatergic transmission may contribute to the therapeutic action of certain atypical antipsychotic agents. Glutamate concentrations were measured in serum and were estimated (Glx/Cr) in cingulate cortex by proton magnetic resonance spectroscopy (MRS) in schizophrenia patients while they were being treated with conventional neuroleptics and then 8 weeks after switching to olanzapine. Serum glutamate concentrations were obtained from 11 subjects, and MRS estimates of Glx/Cr were available from 10 subjects at both time points. Serum glutamate concentrations significantly increased after the switch from conventional agents to olanzapine; brain glutamate (Glx/Cr) did not change significantly; however, brain glutamate (Glx/Cr) concentrations increased significantly in patients who exhibited an improvement in negative symptoms with olanzapine compared with patients with no change or worsening of negative symptoms. Comparisons performed following the switch from conventional agents to olanzapine are consistent with previous studies of clozapine and provide additional preliminary evidence supporting the hypothesis that effects on excitatory amino acid activity may contribute to olanzapine's ...Continue Reading

References

Jan 1, 1990·Progress in Neurobiology·M Erecińska, I A Silver
Mar 1, 1971·Journal of Neurochemistry·T L PerryC Mok
Sep 1, 1995·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·L L WaldD B Vigneron
Sep 1, 1995·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·L L WaldD B Vigneron
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS Hamilton
Jan 1, 1996·Schizophrenia Bulletin·J A StanleyR T Thompson
Apr 1, 1997·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R W ProstS J Li
Jan 1, 1997·Neurobiology of Disease·J T Coyle
Aug 14, 1998·Journal of Magnetic Resonance Imaging : JMRI·M A ThomasJ McCracken
Jan 15, 1999·Clinical and Experimental Pharmacology & Physiology·J Ludbrook
Jan 19, 1999·Archives of General Psychiatry·U Heresco-LevyM Lichtenstein
Sep 5, 2001·The American Journal of Psychiatry·D C Goff, J T Coyle

❮ Previous
Next ❯

Citations

Jul 8, 2005·Psychopharmacology·Charles H LargeDonald C Goff
Apr 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·F M M A van der HeijdenW M A Verhoeven
Mar 11, 2003·Journal of Child and Adolescent Psychopharmacology·Normand CarreyVivek Kusumakar
Jan 15, 2015·Schizophrenia Research·Samuel M CohenMichael M Halassa
Jul 20, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hua-Lin CaiHai-Sen Ye
Oct 13, 2009·Journal of Psychiatric Research·Fabiano G NeryJair C Soares
Dec 12, 2012·Human Psychopharmacology·Igor NenadicStefan Smesny
Mar 24, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Donald C GoffSteven G Potkin
Sep 1, 2004·Biological Psychiatry·Seth D FriedmanPerry F Renshaw
Jun 1, 2006·Biological Psychiatry·Mark A FryeRobert M Post
Sep 12, 2014·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Harpreet KaurRitushree Kukreti
Jun 10, 2015·Psychopharmacology·Laurens J M EversLeopold M G Curfs
Dec 2, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·John D SalamonePhilip McGuire
Jan 15, 2014·Schizophrenia Research·Eline M P PoelsRagy R Girgis
Mar 21, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nico J M van BeverenDurk Fekkes
Nov 27, 2009·Journal of Psychopharmacology·James M StonePhilip K McGuire
Jan 5, 2010·Psychiatry Investigation·Vincenzo De LucaMarcellino Monda
Dec 24, 2005·Harvard Review of Psychiatry·Donald C Goff
Aug 9, 2013·The Journal of Pharmacology and Experimental Therapeutics·Robin H SchmidtGavin E Arteel
Oct 17, 2008·Pharmacological Reviews·Jeffrey A LiebermanJohn G Csernansky
Sep 6, 2019·Psychopharmacology·Alice Egerton
May 11, 2006·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Gulnur Sh BurbaevaMargarita A Morozova
Jan 9, 2019·Frontiers in Psychiatry·Caroline MadeiraRogerio Panizzutti
Oct 12, 2004·CNS Spectrums·Herbert Y Meltzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here